Nyxoah SA (EBR:NYXH)
Belgium · Delayed Price · Currency is EUR 3.730
-0.005 (-0.13%)
Feb 27, 2026, 4:00 PM EST
Nyxoah Market Cap
Nyxoah has a market cap or net worth of €160.49 million as of March 2, 2026. Its market cap has decreased by -57.54% in one year.
Market Cap
160.49M
Enterprise Value
159.17M
Revenue
5.64M
Ranking
n/a
PE Ratio
n/a
Stock Price
€3.73
Market Cap Chart
Since September 18, 2020, Nyxoah's market cap has decreased from 417.77M to 160.49M, a decrease of -61.58%. That is a compound annual growth rate of -16.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 160.49M | -8.69% |
| Dec 31, 2025 | 175.76M | -43.15% |
| Dec 31, 2024 | 309.15M | 153.09% |
| Dec 29, 2023 | 122.15M | -8.05% |
| Dec 30, 2022 | 132.85M | -72.29% |
| Dec 31, 2021 | 479.37M | 37.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 18, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| UCB SA | 47.20B |
| argenx SE | 40.23B |
| Financière de Tubize | 9.95B |
| Fagron NV | 1.64B |
| Ion Beam Applications | 447.63M |
| Onward Medical | 229.63M |
| Hyloris Pharmaceuticals | 199.92M |
| Sequana Medical NV | 43.42M |